(Q34089112)

English

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

Richard E Champlin

1

object named as

Champlin R

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

8

object named as

Giralt S

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

object named as

Khouri I

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Shimoni A

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gajewski J

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Kornblau S

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Molldrem J

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ueno N

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Anderlini P

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 October 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

111

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

18-29

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Identical-twin bone marrow transplants for leukemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Alloreactive CD4+ T lymphocytes can exert cytotoxicity to chronic myeloid leukaemia cells processing and presenting exogenous antigen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Clinical significance of bcr-abl gene rearrangement detected by the polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Transplantation of anergic histoincompatible bone marrow allografts

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Philadelphia-positive metaphases in the marrow after bone marrow transplantation for chronic granulocytic leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02196.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2000.02196.X

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34089112&oldid=1964611954"